ArticleInvestigative ophthalmology & visual science2026
Adrenergic Pathways Mediate Circadian IOP Rhythm in Rats.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circadian Norepinephrine Rhythm Regulates Outflow Facility and IOP in Rat Eyes.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Purpose: This study sought to define adrenergic receptor mechanisms underlying circadian intraocular pressure (IOP) regulation in rats. Methods: IOP was monitored continuously via wireless telemetry in adult Brown-Norway rats entrained to the ambient light/dark (LD) cycle and then maintained in constant darkness (DD). Agonists and antagonists of β- (isoproterenol and timolol), α1- (phenylephrine and bunazosin), and α2- (brimonidine and yohimbine) receptors were applied topically to the cornea during subjective day (SD) and subjective night (SN) in DD. Drug effects were quantified by short-term changes in mean IOP and long-term changes in IOP rhythmicity. Results: Animals exhibited a pronounced IOP rhythm in LD that persisted in DD. IOP was significantly reduced after SN instillation of timolol (DSN% = -110% ± 24%), bunazosin (DSN% = -107% ± 13%), yohimbine (DSN% = -106% ± 12%), and brimonidine (DSN% = -94% ± 18%) and was unchanged after SD instillation. Conversely, IOP was significantly elevated after SD instillation of phenylephrine (DSD% = 143% ± 62%) and isoproterenol (DSD% = 62% ± 19%) and was unchanged after SN instillation. None of the drugs altered IOP rhythm period or phase, but bunazosin abolished the rhythm for several days. Conclusions: Multiple adrenergic receptor pathways participate in the circadian regulation of rat IOP. All are necessary to raise IOP during SN since inactivation of any individual pathway drops IOP fully back to daytime levels. β- and α1-receptor activation is also singularly sufficient to raise IOP during SD to nighttime levels, whereas α2-receptors play a more complex role in IOP regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.